Skip to main content
  • Deaths With Paclitaxel-Coated Devices in PAD Draw FDA Scrutiny

    Agency recommends continued monitoring, not stopping use

    The FDA is investigating a potential safety signal with paclitaxel-coated balloons and stents used to treat peripheral artery disease, it said Thursday in a Dear Doctor letter.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details